Pennsylvania Cannabis Control Board Bill Clears Senate Committee 6-5

Pennsylvania's long, slow path toward modern cannabis governance took a meaningful step this month. The state Senate Law and Justice Committee approved Senate Bill 49 — Sen. Dan Laughlin's proposal to create a stand-alone Pennsylvania Cannabis Control Board (CCB) — on a tight 6-5 vote, sending the measure to the full Senate. The bill does not legalize adult-use marijuana. It is, instead, the regulatory plumbing the commonwealth would need if and when broader reform arrives, and it carries new amendments to align Pennsylvania's hemp rules with the post-Schedule III federal landscape.

For an industry that has watched legalization stall in Harrisburg for years, even a structural reform vote is a signal worth reading carefully.

What Senate Bill 49 Actually Does

SB 49, introduced by Sen. Laughlin (R-49) — who chairs the Law and Justice Committee — would establish the Pennsylvania Cannabis Control Board as the state's central cannabis regulator. The board would absorb oversight of Pennsylvania's medical marijuana program from the Department of Health and consolidate authority over intoxicating hemp products, lab testing standards, and licensing.

In the bill text and Laughlin's accompanying memo, the CCB is framed as a fix for fragmentation. Today, Pennsylvania medical cannabis is supervised by one agency, hemp by another, and intoxicating hemp products — Delta-8, Delta-10, THC-A, and HHC — sit in a regulatory gray zone that consumer protection advocates have spent two years asking the legislature to address. SB 49 collects those threads under a single board with rulemaking authority.

Just as important, the bill is positioned as legalization-ready. If Pennsylvania ever passes adult-use marijuana — Gov. Josh Shapiro's proposed 2026-27 budget pencils in $729 million in new revenue from anticipated adult-use sales — the CCB would already exist to license growers, processors, retailers, and consumption-related businesses without standing up a new agency from scratch.

The 6-5 Vote and the New Hemp Amendments

The committee vote split along an unusual line. The Republican-dominated panel passed the bill 6-5 with all Democrats voting no, joined by Republican Sen. Dawn Keefer of York County. The "no" votes came from concerns about new amendments added before the vote that would ban most hemp-derived THC products sold outside the licensed cannabis system.

Those hemp amendments — quietly tacked on in committee — would align Pennsylvania with the federal Farm Bill direction by banning intoxicating hemp products with more than 0.4 mg of THC per serving and capping total THC by package weight. That is consistent with what Congress is debating nationally, but it is fiercely opposed by Pennsylvania's hemp industry, which has grown into a hundreds-of-millions-of-dollars retail category in gas stations, smoke shops, and online stores statewide.

Democrats voted no in part because they wanted broader patient access and adult-use language attached, and in part because they wanted more time to evaluate the hemp restrictions. Sen. Keefer's defection from the Republican majority reflected hemp-industry pushback from her constituency.

Why This Matters for the Pennsylvania Medical Program

Pennsylvania's medical marijuana program crossed $9.1 billion in cumulative sales earlier this month, with more than 438,000 active patients. The program is one of the largest medical-only markets in the country, and operators have spent years complaining about inconsistent guidance from the Department of Health.

Moving program oversight to a dedicated Cannabis Control Board would, in theory, professionalize that supervision. Other states with CCB-style structures — Massachusetts, Illinois, New York — have generally found that consolidating cannabis regulation under a single body improves licensing throughput, lab standards enforcement, and policy coherence. It also creates a permanent rulemaking forum where the industry, patients, and law enforcement can work through issues without having to lobby the Department of Health on each individual question.

The medical program would not change overnight under SB 49. Existing patient certifications, qualifying conditions, and licensed dispensaries would continue operating. What changes is the regulator on the other side of the table.

What's Next for SB 49

The bill now heads to the full Senate. Republicans hold a slim majority in the chamber, and Laughlin's leadership of the committee — combined with backing from operators who have grown tired of the regulatory drift — gives SB 49 a real, if not overwhelming, path forward. Floor passage in the Senate would send the bill to the Democrat-controlled House, where it would land in a chamber that has historically been more receptive to cannabis reform but more skeptical of standalone regulatory bills that don't also legalize adult-use.

Gov. Shapiro has been unambiguous about wanting adult-use legalization. His office has not formally weighed in on SB 49 as a stand-alone measure, but advocates expect the governor to view it as complementary infrastructure for the broader legalization push.

Laughlin himself has said publicly that adult-use legalization is "probably on the horizon" for Pennsylvania, even though previous bills have died in the Senate. The CCB framework is, in that sense, the runway. If Pennsylvania does flip in the next two budget cycles, a Cannabis Control Board that already exists will move legalization implementation forward by months.

The Hemp Industry Fight

The hemp THC restrictions in the amended SB 49 are the part of the bill most likely to draw lobbying fire in the coming weeks. Pennsylvania's hemp THC retail category has exploded since 2022, with consumers buying federally legal Delta-8 gummies and high-milligram THC-A flower at convenience stores at prices well below licensed medical cannabis products.

Licensed cannabis operators have argued — in Pennsylvania and nationally — that intoxicating hemp products represent an unregulated shadow market that undercuts state-licensed cannabis without paying the same taxes, lab fees, or compliance costs. Hemp retailers counter that the products are legal under the 2018 Farm Bill and that abrupt restrictions threaten thousands of small businesses.

SB 49's hemp provisions tee that fight up for floor debate. If the Senate keeps the hemp restrictions intact, expect a significant outside-money lobbying campaign on both sides. If the Senate amends them out to keep the CCB framework alive, hemp operators get a reprieve — but the structural fight returns whenever Pennsylvania does pass adult-use.

Key Takeaways

• Pennsylvania's Senate Law and Justice Committee passed SB 49 on a 6-5 vote, advancing Sen. Dan Laughlin's bill to create a state Cannabis Control Board.
• The bill does not legalize adult-use marijuana; it consolidates medical and hemp oversight under one regulator and is designed to be ready if legalization passes later.
• New amendments would restrict most intoxicating hemp products with more than 0.4 mg of THC per serving, drawing opposition from Pennsylvania's hemp industry.
• Gov. Shapiro's 2026-27 budget assumes $729 million in adult-use revenue, signaling that a CCB structure may be a precursor to broader legalization.
• The bill now goes to the full Senate, where the hemp restrictions are likely to draw the most lobbying attention.

Tracking how PA's regulatory overhaul stacks up against the rest of the country? Browse Budpedia's directory of verified cannabis dispensaries — every listing checked against state license rolls before going live — and keep an eye on state-level moves on the cannabis legalization tracker.